AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITP

Abstract

AMG 531 caused no major adverse events and increased platelet counts in patients with ITP. (ClinicalTrials.gov number, NCT00111475 [ClinicalTrials.gov].).